These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10847422)

  • 1. Influence of exogenous factor VIIa on thrombin generation in cord plasma of full-term and pre-term newborns.
    Streif W; Paes B; Berry L; Andrew M; Andreasen RB; Chan AK
    Blood Coagul Fibrinolysis; 2000 Jun; 11(4):349-57. PubMed ID: 10847422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential.
    Chan AK; Berry LR; Monagle PT; Andrew M
    Thromb Haemost; 2002 Apr; 87(4):606-13. PubMed ID: 12008942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible mechanism of action of activated factor VII independent of tissue factor.
    Monroe DM; Hoffman M; Oliver JA; Roberts HR
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S15-20. PubMed ID: 9819024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VIIa-mediated tenase function on activated platelets under flow.
    Goel MS; Diamond SL
    J Thromb Haemost; 2004 Aug; 2(8):1402-10. PubMed ID: 15304047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of dabigatran effects in models of thrombin generation and hemostasis by factor VIIa and prothrombin complex concentrate.
    Hoffman M; Volovyk Z; Monroe DM
    Anesthesiology; 2015 Feb; 122(2):353-62. PubMed ID: 25502064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
    Tomokiyo K; Nakatomi Y; Araki T; Teshima K; Nakano H; Nakagaki T; Miyamoto S; Funatsu A; Iwanaga S
    Vox Sang; 2003 Nov; 85(4):290-9. PubMed ID: 14633255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha 2-Macroglobulin remains as important as antithrombin III for thrombin regulation in cord plasma in the presence of endothelial cell surfaces.
    Ling X; Delorme M; Berry L; Ofosu F; Mitchell L; Paes B; Andrew M
    Pediatr Res; 1995 Mar; 37(3):373-8. PubMed ID: 7540283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa.
    Veldman A; Hoffman M; Ehrenforth S
    Curr Med Chem; 2003 May; 10(10):797-811. PubMed ID: 12678684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
    Hoffman M; Monroe DM
    Dis Mon; 2003 Jan; 49(1):14-21. PubMed ID: 12525825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of covalent serpin-heparinoid complexes on plasma thrombin generation on fetal distal lung epithelium.
    Berry LR; Klement P; Andrew M; Chan AK
    Am J Respir Cell Mol Biol; 2003 Feb; 28(2):150-8. PubMed ID: 12540482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin sensitivity and resistance in the neonate: an explanation.
    Vieira A; Berry L; Ofosu F; Andrew M
    Thromb Res; 1991 Jul; 63(1):85-98. PubMed ID: 1658964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of synthetic pentasaccharide, low-molecular-weight heparin, unfractionated heparin and recombinant hirudin on the generation of factor VIIa and prothrombin activation after coagulation of human plasma.
    Gerotziafas GT; Bara L; Bloch MF; Makris PE; Samama MM
    Blood Coagul Fibrinolysis; 1998 Oct; 9(7):571-80. PubMed ID: 9863704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of activated factor VII concentrates on thrombin generation in full-term and preterm neonates.
    Streif W; Borum Andreasen R; Paes B; Berry L; Xu L; Andrew M; Chan AK
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S133-4. PubMed ID: 10850579
    [No Abstract]   [Full Text] [Related]  

  • 14. Combining FVIIa and FX into a mixture which imparts a unique thrombin generation potential to hemophilic plasma: an in vitro assessment of FVIIa/FX mixture as an alternative bypassing agent.
    Nakatomi Y; Nakashima T; Gokudan S; Miyazaki H; Tsuji M; Hanada-Dateki T; Araki T; Tomokiyo K; Hamamoto T; Ogata Y
    Thromb Res; 2010 May; 125(5):457-63. PubMed ID: 20080285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant effects of heparin in neonatal plasma.
    Schmidt B; Ofosu FA; Mitchell L; Brooker LA; Andrew M
    Pediatr Res; 1989 Apr; 25(4):405-8. PubMed ID: 2726317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa.
    Ollivier V; Chabbat J; Herbert JM; Hakim J; de Prost D
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1374-81. PubMed ID: 10807756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation.
    Gerotziafas GT; Chakroun T; Depasse F; Arzoglou P; Samama MM; Elalamy I
    Thromb Haemost; 2004 May; 91(5):977-85. PubMed ID: 15116259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of heparins on thrombin generation in hemophilic plasma supplemented with FVIII, FVIIa, or FEIBA.
    Parmar N; Berry LR; Paredes N; Chan AK
    Clin Lab; 2005; 51(3-4):157-66. PubMed ID: 15819171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-dependent thrombin generation assay for monitoring the efficacy of recombinant Factor VIIa.
    Wegert W; Harder S; Bassus S; Kirchmaier CM
    Platelets; 2005 Feb; 16(1):45-50. PubMed ID: 15763896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease.
    Baroni M; Martinelli N; Lunghi B; Marchetti G; Castagna A; Stefanoni F; Pinotti M; Woodhams B; Olivieri O; Bernardi F
    Thromb Res; 2020 May; 189():140-146. PubMed ID: 32224381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.